Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

ClinicalTrials.gov ID: NCT05052697

Public ClinicalTrials.gov record NCT05052697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be divided into two substudies - Substudy A (SSA) and Substudy B (SSB) Substudy A This is a Phase 1 randomized substudy to evaluate the safety and immunogenicity of monovalent influenza modRNA vaccine (mIRV) and bivalent influenza modRNA vaccine (bIRV) at various dose levels, and quadrivalent influenza modRNA vaccine (qIRV), in participants 65 to 85 years of age. Participants will receive at Vaccination 1 either: * 1 of 4 dose levels of mIRV (either A or B Strain), * 1 of 4 dose levels of bIRV (containing both A and B strains), * qIRV (at 1 dose level), or * A licensed quadrivalent influenza vaccine (QIV). At approximately 8 weeks following Vaccination 1, participants will be unblinded and QIV (Vaccination 2) administered to participants not having previously received this at Vaccination 1. Additionally, participants who previously received QIV at Vaccination 1 will receive one of the following for Vaccination 2: * mIRV encoding A strain at dose level 4, or * mIRV encoding B strain at dose level 4. Substudy B This is a randomized substudy to evaluate the safety and immunogenicity of the following vaccination schedules in participants 65 to 85 years of age: 2-Visit Schedules * 2 doses of qIRV (at a dose level 1), administered 21 days apart. * 2 doses of licensed QIV, administered 21 days apart (as a control group) * A dose of licensed QIV following by a dose of bIRV encoding 2 A strains at dose level combination 1 or 2, administered 21 days apart. 1-Visit Schedules * A dose of licensed QIV administered concurrently in the opposite arm with bIRV encoding 2 A strains at dose level combination 1 or 2. * A dose of bIRV encoding 2 A strains administered concurrently in the opposite arm with a dose of bIRV encoding 2 B strains.at dose level 1. * A dose of qIRV encoding 2 A strains and 2 B strains at dose level 2 (at one of two possible dose level combinations). * A dose of qIRV encoding 2 A strains and 2 B strains at dose level 3. * 1 dose of licensed QIV (as a control group). Substudy B In participants 18 to 64 years of age: -A dose of qIRV encoding 2 A strains and 2 B strains at a dose level combination 1 or 2.

Study identification

NCT ID
NCT05052697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
1,158 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 13, 2021 (Actual)
Primary completion
Jan 27, 2023 (Actual)
Completion
Jan 27, 2023 (Actual)
Last update posted
Mar 12, 2024

2021 – 2023

United States locations

U.S. sites
100
U.S. states
22
U.S. cities
61
Facility City State ZIP Site status
North Alabama Research Center Athens Alabama 35611 —
The Heart Center Athens Alabama 35611 —
Arizona Heart Rhythm Center Phoenix Arizona 85016 —
HOPE Research Institute Phoenix Arizona 85018 —
The Pain Center of Arizona Phoenix Arizona 85018 —
Noble Clinical Research Tucson Arizona 85704 —
Pima Heart and Vascular Tucson Arizona 85704 —
Inland Valley Cardiovascular Center Murrieta California 92563 —
Orange County Heart Institute Orange California 92868 —
Artemis Institute for Clinical Research Riverside California 92503 —
Orange County Research Center Tustin California 92780 —
Pediatrics-Infectious Diseases - Clinical Trials Center at University of Colorado Anschutz Medical C Aurora Colorado 80045 —
UCHealth Heart and Vascular Center - Anschutz Medical Campus Aurora Colorado 80045 —
Yale University School of Medicine New Haven Connecticut 06510 —
Yale Cardiology New Haven Connecticut 06519 —
Yale University School of Medicine New Haven Connecticut 06519 —
Alliance for Multispecialty Research, LLC Coral Gables Florida 33134 —
Halifax Health Medical Center Daytona Beach Florida 32114 —
NYU Langone Cardiology Associates Delray Beach Florida 33484 —
First Coast Heart & Vascular Center Fleming Island Florida 32003 —
Fleming Island Center for Clinical Research Fleming Island Florida 32003 —
Proactive Clinical Research,LLC Fort Lauderdale Florida 33308 —
Alliance for Multispecialty Research, LLC Fort Myers Florida 33912 —
Millennium Physician Group Fort Myers Florida 33912 —
Robert B. Pritt, DO Fort Myers Florida 33912 —
Direct Helpers Research Center. Hialeah Florida 33012 —
Best Quality Research,Inc. Hialeah Florida 33016 —
Elixia Infectious Disease, LLC Hollywood Florida 33024 —
First Coast Heart & Vascular Center Jacksonville Florida 32216 —
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256 —
First Coast Cardiovascular Institute Jacksonville Florida 32256 —
Premier Cardiology and Vascular Associates Maitland Florida 32751 —
LMG Research Miami Florida 33125 —
Millennium Clinical Research Miami Florida 33125 —
Optimus U Corporation Miami Florida 33125 —
Suncoast Research Group Miami Florida 33135 —
Schiff Center for Liver Diseases/University of Miami Miami Florida 33136 —
University of Miami Hospital Miami Florida 33136 —
Dr Gerardo A. Polanco, MD Miami Florida 33156 —
Research Institute of South Florida Miami Florida 33173 —
Entrust Clinical Research Miami Florida 33176 —
Jackson Medical Group Cardiac Care Miami Florida 33176 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Central Florida Cardiology Group Orlando Florida 32803 —
Innovation Medical Research Center Palmetto Bay Florida 33157 —
DBC Research USA Pembroke Pines Florida 33029 —
Progressive Medical Research Port Orange Florida 32127 —
My Cardiologist South Miami Florida 33143 —
Precision Clinical Research Sunrise Florida 33351 —
Genesis Clinical Research, LLC Tampa Florida 33603 —
Conquest Research Winter Park Florida 32789 —
Centricity Research Columbus Georgia Multispecialty Columbus Georgia 31904 —
IACT Health Columbus Georgia 31904 —
IACT Health Rincon Georgia 31326 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
University of Iowa Iowa City Iowa 52242 —
Alliance for Multispecialty Research, LLC Wichita Kansas 67205 —
Alliance for Multispecialty Research, LLC Wichita Kansas 67207 —
Heartland Cardiology, LLC Wichita Kansas 67226 —
Centennial Medical Group Elkridge Maryland 21075 —
Associates of Cardiology Silver Spring Maryland 20910 —
Henry Ford Hospital Detroit Michigan 48202 —
Pioneer Heart Institute Lincoln Nebraska 68506 —
Velocity Clinical Research, Norfolk Norfolk Nebraska 68701 —
Meridian Clinical Research - 3345 North 107th Street Omaha Nebraska 68134 —
Velocity Clinical Research, Omaha Omaha Nebraska 68134 —
Sanjay Vohra, MD, F.A.C.C. Henderson Nevada 89074 —
Wr-Crcn, Llc. Las Vegas Nevada 89106 —
Excel Clinical Research, LLC Las Vegas Nevada 89109 —
Las Vegas Clinical Trials North Las Vegas Nevada 89030 —
Hassman Research Institute Berlin New Jersey 08009 —
Penn Medicine Somers Point New Jersey 08244 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
NYU Langone - Center for the Prevention of Cardiovascular Disease New York New York 10016 —
NYU Langone Health New York New York 10016 —
Rochester General Hospital Infectious Disease Rochester New York 14621 —
Rochester General Hospital Rochester New York 14621 —
University of Rochester Medical Center Rochester New York 14642 —
Upstate Health Care Center-University Cardiovascular Group of Syracuse Syracuse New York 13202 —
SUNY Upstate Medical University Global Health Research Unit Syracuse New York 13215 —
M3-Emerging Medical Research, LLC Durham North Carolina 27704 —
Carolina Institute for Clinical Research Fayetteville North Carolina 28303 —
Monroe Biomedical Research Monroe North Carolina 28112 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Aventiv Research Inc. Columbus Ohio 43213 —
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213 —
Columbus Cardiovascular Associates, Inc Columbus Ohio 43213 —
Pennsylvania Heart and Vascular Group Jenkintown Pennsylvania 19046 —
Main Street Physician's Care Little River South Carolina 29566 —
Prolato Clinical Research Center Houston Texas 77054 —
DM Clinical Research Houston Texas 77065 —
DM Clinical Research Humble Texas 77338 —
Cedar Health Research Irving Texas 75062 —
Harmony Heart Group Plano Texas 75093 —
Mt Olympus Medical Research Sugar Land Texas 77479 —
DM Clinical Research Tomball Texas 77375 —
Northwest Heart Center Tomball Texas 77375 —
Centricity Research Suffolk Primary Care Suffolk Virginia 23435 —
Sentara BelleHarbour Suffolk Virginia 23435 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05052697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2024 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05052697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →